S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TNXP Tonix Pharmaceuticals Holding Corporation

0.133

-0.007 (-5.00%)

16 Nov 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals Holding Corporation News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 days ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Thursday 14 November 2024 (3 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 14 November 2024 (3 days ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
Thursday 14 November 2024 (3 days ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (4 days ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Wednesday 13 November 2024 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 9 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Monday 4 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 1 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
Friday 1 November 2024 (2 weeks ago) • GlobeNewswire Inc.

More Tonix Pharmaceuticals Holding Corporation News Articles

Midland States Bancorp

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions